Prosecution Insights
Last updated: November 18, 2026
Application No. 19/230,347

NON-AQUEOUS SPRAYABLE AND CURABLE DAMPENING COMPOSITIONS FOR AUTOMOTIVE BODY AND CLOSURE PANELS AND ASSOCIATED METHODS FOR CURING AND USING THE SAME

Non-Final OA §102§103§DOUBLEPATENT
Filed
Jun 06, 2025
Priority
Aug 04, 2023 — continuation of 12/415,933
Examiner
PROCTOR, CACHET I
Art Unit
1712
Tech Center
1700 — Chemical & Materials Engineering
Assignee
UNISEAL INC.
OA Round
1 (Non-Final)
77%
Grant Probability
Favorable
1-2
OA Rounds
83%
With Interview

Examiner Intelligence

Grants 77% — above average
77%
Career Allowance Rate
837 granted / 1084 resolved
+12.2% vs TC avg
Moderate +6% lift
Without
With
+5.8%
Interview Lift
resolved cases with interview
Typical timeline
Avg Prosecution
34 currently pending
Career history
1140
Total Applications
across all art units

Office Action

§102 §103 §DOUBLEPATENT
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 1-20 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-25 of U.S. Patent No. 12415933. Although the claims at issue are not identical, they are not patentably distinct from each other because claim 1 of ‘933 recites a non-aqueous sprayable and curable dampening composition for automotive body and closure panels which cures to form a curable product, comprising: a PVC homopolymer and/or mixture of a PVC copolymer resin; a phthalate plasticizer and a benzoate plasticizer; a filler component, where the filler component comprises one or more spherical or platy fillers; a modified epoxy resin; an adhesion promoter comprising epoxy based silane and a substrate wetting agent which anticipates claims 1, 19, and 20 of the current application. The dependent claims of ‘933 anticipates the current claims 2-18. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1-2, 5, 7-8, 10, 11, 16, and 18 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Wesch et al. (US 5756555) . As to claim 1, Wesch et al. disclose a sprayable acoustically active plastisol (see abstract) comprising a copolymer based on vinyl chloride and vinyl acetate (see abstract); plasticizer (phthalate, benzoate – see col. 4, lines 36-48); filler (calcium carbonate in the form of mica or chalks- see col. 4 lines 49-53); epoxy resins (see col. 5, line 5); coupling agent (wetting agent/ adhesion promoter- see col. 5, lines 6-12). Wesch et al. discloses using the plastisol by applying to a substrate and curing where a foam is formed (resulting in interpenetrating network of resin) (see claims 26-27, col. 5). As to claim 2, the composition is solvent-free. As to claim 5, the filler is up to 40% (see claim 13). As to claims 7-8, the coupling agent is provided at 0.01-5% (see claim 1). As to claim 10, the plasticizers are diisononyl phthalate (see claim 7) and dibenzoate (see col. 4, lines 36-48). As to claim 11, the platy to spherical filler is about 20:1 (see examples). As to claim 16, the curing agent is dicyanamide (See claim 11). As to claim 18, the composition comprises calcium oxide (see claim 29). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim(s) 3-4 and 9 is/are rejected under 35 U.S.C. 103 as being unpatentable over Wesch et al. (US 5756555). The teachings of Wesch as applied to claim 1 are as stated above. Wesch fails to teach the range of 20-40 as required by claim 3, 20-50 as required by claim 4, and the claimed molecular weight required by claim 9. As to claim 3, Wesch teaches the copolymer resin is provided at 5-60% (see claim 1). In the case where the claimed ranges "overlap or lie inside ranges disclosed by the prior art" a prima facie case of obviousness exists. In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976); In re Woodruff, 919 F.2d 1575, 16 USPQ2d 1934 (Fed. Cir. 1990). As to claim 4, the plasticizer is provided at 5-65% (See claim 1). In the case where the claimed ranges "overlap or lie inside ranges disclosed by the prior art" a prima facie case of obviousness exists. In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976); In re Woodruff, 919 F.2d 1575, 16 USPQ2d 1934 (Fed. Cir. 1990). As to claim 9, the K value for the PVC is 40-80 (see col. 4, lines 29-31) which would equate to 20,000 to 400,000 Daltons. In the case where the claimed ranges "overlap or lie inside ranges disclosed by the prior art" a prima facie case of obviousness exists. In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976); In re Woodruff, 919 F.2d 1575, 16 USPQ2d 1934 (Fed. Cir. 1990). Claim(s) 6, 12, and 15 is/are rejected under 35 U.S.C. 103 as being unpatentable over Wesch et al. (US 5756555) as applied to claim 1 above, in view of Eadara et al. (US 2006/0040096). The teachings of Wesch as applied to claim 1 are as stated above. Wesch fail to disclose the claimed range of epoxy resin as required by claim 6 or the type of modified epoxy as required by claim 12. Eadara et al. discloses an acoustic damping material that is formed of PVS resin; filler (carbon carbonate); phthalate plasticizer; and bisphenol A (see 0023). The bisphenol A is provided at 10% (see 0023). It would have been obvious to one having ordinary skill in the art before the effective filing date to modify the composition of Wesch to include the epoxy at the claimed range as taught by Eadara et al. One would have been motivated to do so since both are directed to damping compositions having modified epoxies where Eadara et al. teaches an operable epoxy and amount useful with PVC. Eadara et al. teaches the use of fumed silica (See 0022). It would have been obvious to use the silica in the composition of Wesch since both are directed to damping compositions of PVC where Eadara et al. teaches an alternative filler. It has been established that the mere substitution of one known element for another with the same intended use has predictable results. As to claim 15, Eadara et al. teaches the use of fumed silica (see 0022-23). Claim(s) 13, 19, and 20 is/are rejected under 35 U.S.C. 103 as being unpatentable over Wesch et al. (US 5756555) as applied to claim 1 above in view of Pluddemann (US 4961967). The teachings of Wesch et al. as applied to claim 1 are as stated above. As to claims 19 and 20, Wesch et al. disclose a sprayable acoustically active plastisol (see abstract) comprising a copolymer based on vinyl chloride and vinyl acetate (see abstract); plasticizer (phthalate, benzoate – see col. 4, lines 36-48); filler (calcium carbonate in the form of mica or chalks- see col. 4 lines 49-53); epoxy resins (see col. 5, line 5); coupling agent (wetting agent/ adhesion promoter- see col. 5, lines 6-12). Wesch et al. discloses using the plastisol by applying to a substrate and curing where a foam is formed (resulting in interpenetrating network of resin) (see claims 26-27, col. 5). Wesch et al. fails to teach the adhesion promoter comprises an epoxy based silane as required by claims 13, 19, and 20. Pluddemann teaches the use of epoxy-functional silanes containing adhesion promoters that can be incorporated into PVC plastisols in order to improve the adhesion to metallic, mineral or plastic substrates (see abstract, col. 4, line 57-68). It would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to modify the composition of Wesch et al. to include the epoxy based silane of Pluddemann as the adhesion promoter. One would have been motivated to do so since Wesch et al. teaches the use of adhesion promoters, where Pluddeman teaches operable adhesion promoters that can be added to PVC plastisols to improve its adhesion to substrates. Conclusion There are no prior art rejections over claims 14 and 17. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Cachet I Proctor whose telephone number is (571)272-0691. The examiner can normally be reached Monday-Friday 7-3 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Michael Cleveland can be reached at 571-272-1418. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /CACHET I. PROCTOR/ Examiner Art Unit 1712 /CACHET I PROCTOR/Primary Examiner, Art Unit 1712
Read full office action

Prosecution Timeline

Jun 06, 2025
Application Filed
Oct 20, 2026
Non-Final Rejection mailed — §102, §103, §DOUBLEPATENT (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12785039
Method and System for Plasma Process
3y 0m to grant Granted Nov 03, 2026
Patent 12766216
SUTURE ENCAPSULATION PROCESSES AND SYSTEMS
3y 1m to grant Granted Oct 20, 2026
Patent 12753511
CHEMICAL VAPOR DEPOSITION EQUIPMENT AND METHOD THEREFOR
2y 4m to grant Granted Oct 06, 2026
Patent 12741063
CONFORMAL, NON-OCCLUDING SENSOR ARRAY FOR CARDIAC MAPPING AND ABLATION
2y 3m to grant Granted Sep 22, 2026
Patent 12741065
WATER-BASED HYDROGEL BLEND COATING AND METHOD OF APPLICATION TO ELASTOMERIC ARTICLES
1y 9m to grant Granted Sep 22, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
77%
Grant Probability
83%
With Interview (+5.8%)
Low
PTA Risk
Based on 1084 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month